The long-term efficacy and safety of apatinib are inferior to sorafenib in the first-line treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis
Article in Medicine (January 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Transarterial interventional therapy combined with tyrosine kinase inhibitors with or without anti-PD-1 antibodies as initial treatment for hepatocellular carcinoma with major portal vein tumor thrombosis: a single-center retrospective study
Article in Cancer Immunology, Immunotherapy (August 2023)
Comparative efficacy and safety of molecular targeted agents combined with transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: a network meta-analysis
Article in Frontiers in Oncology (May 2023)